June 22, 2023 | Issue #56

Good morning! Did you check out our recently launched 'Ultimate Guide to Increasing Your Healhspan & Lifespan' yet?  Go check it out now, if you haven't already. In this week's newsletter:🩸 Top 5 Epigenetic Age Tests💰 Vincere Biosciences lands big investors🌐 Energy drinks = longer life? (Not quite)

Top 5 Epigenetic Tests

Similar to a vehicle diagnostic test, getting a ‘look under the hood’ with an epigenetic age test can play an important role in deciding what future health choices to make.

Our vulnerability to various diseases and health issues tends to increase as we age, highlighting the importance of understanding the aging process.

We take a look at the top 5 epigenetic tests currently available on the market, so you can compare which one is right for you. 

• AgelessRx is hiring a CRM Marketing Specialist with a starting salary of $65,000. APPLY HERE. 

• Parsley Health is hiring a VP of Sales, with a starting salary of $170k. APPLY HERE. 

• Browse thousands of jobs in the longevity industry, updated daily, in Spannr's new Jobs database HERE. 

• No funding announcements for this week 😱! 

• The Curious Connection Between Psychedelics and Longevity Part II (The Trip Report)

• Police got called to an overcrowded presentation on “rejuvenation” technology (Technology Review)

• Longevity Isn’t Really About Our Genes, Study Reveals (The Epoch Times)

• Human Digital Twins: The Next Frontier in Aging and Longevity Research (CityLife)

• PIF launches Lifera to boost pharma manufacturing in Kingdom (Arab News)

• Longevity pioneer Peter Attia explains why the quest to live longer is constrained by the US healthcare system (Business Insider)

• Americans could live an average of 12 years longer by 2040, according to a new report. But employers must lead the charge (Fortune)

• Chris Hemsworth’s Centr Partners with Lifespan.io, to Make Health, Wellness and Longevity Education More Accessible for All (Business Wire)

Performance:

Latest Price: $125.547d-Return: -2.8%Market Cap: $12.86b

Big Movers:Mesoblast (MESO): 20.33%Humacyte (HUMA): -16.81%Miromatrix (MIRO): 16.2%

ABOUT SPANNR

We are dedicated to helping people understand the biggest business and health story of all time: the unprecedented transformation of society that will result from extending human healthspan and lifespan.

If you have any questions about Spannr or want to get to know us better, 

contact us

 – we'd love to hear from you. We appreciate your interest in what we are creating.